Tran-Scell Biologics Private Limited - Company Profile

It is a healthcare private limited company based in Hyderabad, Telangana, India, established in 2009.

2009 Hyderabad, Telangana, India Active

Last Updated: December 22, 2025

About Tran-Scell Biologics Private Limited

Tran-Scell Biologics Private Limited, a active private limited company, was established on 07 December 2009 in Hyderabad, Telangana, India. Engaging in diabetes care & endocrinology clinics within the professional, scientific and technical sector, it holds CIN: U85100TG2009PTC066172. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹3.22 Cr and a paid-up capital of ₹3.14 Cr.

It upholds a compliant status. Its leadership includes Uday Chatterjee (Director), Vinayender Tulla (Director), Subhadra Dravida (Managing Director). Past directors included Bhim Sain Bajaj, Uday Chatterjee, Sanjay Vijay Singh Jesrani. It holds no open charges and ₹1.95 Cr settled loans. Its latest AGM occurred on 26 September 2025, with the balance sheet filed on 31 March 2025. It is based at 8Th Floor, Western Pearl, Kondapur, Hyderabad, Telangana, 500084.

Company Details

CIN/LLPIN
U85100TG2009PTC066172
Registration Number
066172
Incorporation Date
07 December 2009
Authorized Capital
₹3.22 Cr
Paid-Up Capital
₹3.14 Cr
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 3.22 Cr as on 22-12-2025
Paid Up Capital ₹ 3.14 Cr as on 22-12-2025
Company Age 16 Year, 2 Months
Last Filing with ROC 31 Mar 2025
Satisfied Charges ₹ 1.95 Cr as on 22-12-2025
Revenue Growth **** -36.79% (FY 2023)
Profit Growth **** -17.51% (FY 2023)
Ebitda **** -82.80% (FY 2023)
Net Worth -12.26% (FY 2023)
Total Assets -9.74% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Tran-Scell Biologics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Tran-Scell Biologics Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Uday Chatterjee	Director	11 May 2020	Current
Vinayender Tulla	Director	05 Oct 2015	Current
Subhadra Dravida	Managing Director	07 Dec 2009	Current
Asif Wahidul Hasan	Director	25 Jul 2024	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	29 Nov 2014	Past
Pramod Abcsdd	Additional Director	31 Dec 2020	Past
Pramod Abcsdd	Director	07 May 2020	Past
Pramod Abcsdd	Additional Director	29 Sep 2017	Past
Pramod Abcsdd	Director	25 Oct 2021	Past
Pramod Abcsdd	Additional Director	02 Jan 2016	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Tran-Scell Biologics.

Tran-Scell Biologics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 36.79% decrease. The company also saw a substantial fall in profitability, with a 17.51% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.26%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-36.79%

*******

Revenue from Operations

*******

-35.22%

*******

Total Assets

*******

-9.74%

*******

Profit or Loss

*******

-17.51%

*******

Net Worth

*******

-12.26%

*******

EBITDA

*******

-82.80%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Tran-Scell Biologics?

In 2023, Tran-Scell Biologics had a promoter holding of 62.39% and a public holding of 37.61%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹19,500,000.00

Charges Breakdown by Lending Institutions

Andhra Pradesh State Financial Corporation : 1.55 Cr
Others : 0.40 Cr

Latest Charge Details

Date	Lender	Amount	Status
22 Jun 2012	Others	₹4.00 M	Satisfied
21 May 2010	Andhra Pradesh State Financial Corporation	₹1.55 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Tran-Scell Biologics?

Unlock and access historical data on people associated with Tran-Scell Biologics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Tran-Scell Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tran-Scell Biologics's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Tran-Scell Biologics

Recent Activity within the Organization

Annual General Meeting

Tran-Scell Biologics Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records. was recorded as a recent event.
26 Sep 2025
Charges

Progress on A charge registered on 22 Jun 2012 via Charge ID 10366630 with Others was fully satisfied on 20 Jun 2025. was documented.
20 Jun 2025
Balance Sheet

Progress on Tran-Scell Biologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.
31 Mar 2025
Director Appointment

The activity Asif Wahidul Hasan was appointed as a Director was appointed as a Director on 25 Jul 2024 & has been associated with this company since 1 year 6 months . was completed.
25 Jul 2024
Charges

A charge with Others of Rs. 0.40 Cr registered on 22 Jun 2012 with Charge ID 10366630 was modified on 21 Sep 2021. was recorded as a recent event.
21 Sep 2021
Director Appointment

The activity Uday Chatterjee was appointed as a Director was appointed as a Director on 11 May 2020 & has been associated with this company since 5 years 9 months . was completed.
11 May 2020

Explore recent activity and updates - View Recent Activity